4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000899243-22-028370
Options or other derivatives
- Chief Operating Officer acquired 137,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hayes Melvin H. III Chief Operating Officer | 2022-08-09 | Grant or award · Stock Option (right to buy) | +137,000 | 137,000 | D | ||
Loading xslF345X03/doc4.xml…